Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cartesian Therapeutics, Inc. | Chief Medical Officer | Common Stock | 18.3K | $313K | $17.14 | Nov 15, 2024 | Direct |
Cartesian Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 30.5K | $24.1K | $0.79 | Nov 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics, Inc. | Nov 14, 2024 | 6 | -$730K | 4 | Nov 18, 2024 | Chief Medical Officer |
RNAC | Cartesian Therapeutics, Inc. | Apr 8, 2024 | 2 | $0 | 4 | Apr 10, 2024 | Chief Medical Officer |
RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Medical Officer |
SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 1 | $0 | 4 | Nov 15, 2023 | Chief Medical Officer |
SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 0 | $0 | 3 | Nov 15, 2023 | Chief Medical Officer |